Teva Pharmaceutical Industries Other Non-Current Liabilities 2010-2024 | TEVA
Teva Pharmaceutical Industries other non-current liabilities for the quarter ending June 30, 2024 were $4.356B, a 9.64% increase year-over-year.
- Teva Pharmaceutical Industries other non-current liabilities for 2023 were $4.019B, a 1.88% increase from 2022.
- Teva Pharmaceutical Industries other non-current liabilities for 2022 were $3.945B, a 53.03% increase from 2021.
- Teva Pharmaceutical Industries other non-current liabilities for 2021 were $2.578B, a 15.09% increase from 2020.